Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | GAA | P10253 | 8/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | JAK1 | P23458 | 1/20 | 0.51 |
| ▸ | TYK2 | P29597 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL105255 | 0.86 | CES2 (0.64) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL2876974 | 0.84 | GAA (0.58) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL15578239 | 0.84 | CES2 (0.61) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL103586 | 0.84 | ALDH1A1 (1.00) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL695459 | 0.83 | GAA (0.56) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL29570977 | 0.83 | GAA (0.56) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL11179271 | 0.83 | GAA (0.56) | ALDH1A1GAACES2CES1JAK2 | |
| Methane SCHEMBL28290707 | 0.81 | ALDH1A1 (0.95) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL716550 | 0.81 | GAA (0.54) | ALDH1A1GAACES2CES1JAK2 | |
| SCHEMBL29443043 | 0.81 | GAA (0.54) | ALDH1A1GAACES2CES1JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110818556-A | Method for producing high-purity 2-chloro-6-fluorobenzoyl chloride by using waste residues | 浙江大洋生物科技集团股份有限公司 | 2020-02-21 | — | — | CN | claimed |
| EP-1506176-B1 | AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PFIZER ITALIA SRL (IT) | 2013-04-24 | — | — | EP | claimed |
| US-12552804-B2 | Tricyclic heterocycles as FGFR inhibitors | INCYTE CORPORATION (US) | 2026-02-17 | — | — | US | disclosed |
| US-12545682-B2 | Heterocyclic derivatives as P2X7 receptor antagonists | BREYE THERAPEUTICS APS (DK) | 2026-02-10 | — | — | US | disclosed |
| EP-4665705-A1 | A PROCESSES FOR THE PREPARATION OF BENZONITRILE COMPOUNDS FROM THE CORRESPONDING BENZOTRICHLORIDE COMPOUNDS | Aarti Industries Limited (IN) | 2025-12-24 | — | — | EP | disclosed |
| US-12410174-B1 | Small molecular inhibitors of sting signaling compositions and methods of use | TYERELL IMMUNOTHERAPEUTICS INC (US) | 2025-09-09 | — | — | US | disclosed |
| EP-4541422-A2 | QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS | Gilead Sciences, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| WO-2025061035-A1 | BRM SELECTIVE DEGRADATION AGENT COMPOUND AND USE THEREOF | 南京再明医药有限公司 | 2025-03-27 | — | — | WO | disclosed |
| EP-4262975-B1 | HETEROCYCLIC DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | BREYE THERAPEUTICS APS (DK) | 2025-03-05 | — | — | EP | disclosed |
| CN-119462635-A | Quinoline derivatives as alpha 4 beta 7 integrin inhibitors | 吉利德科学公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250032473-A1 | QUINOLINE DERIVATIVES | GILEAD SCIENCES, INC. | 2025-01-30 | — | — | US | disclosed |
| EP-0261459-A2 | N-benzothiazolyl amides | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1988-03-30 | — | — | EP | disclosed |
| EP-0113151-B1 | PRINTING MEDIUM AND USE THEREOF | International Business Machines Corporation (US) | 1988-03-09 | — | — | EP | disclosed |
| US-4675331-A | INSECTICIDE | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1987-06-23 | — | — | US | disclosed |
| EP-0208321-A2 | Triazole derivatives, their preparation and their use as pesticides | CIBA-GEIGY AG (CH) | 1987-01-14 | — | — | EP | disclosed |
| CN-86102102-A | Preparation technology of new benzamides and uses thereof | — | 1987-01-07 | — | — | CN | disclosed |
| EP-0196547-A1 | Benzamides | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-10-08 | — | — | EP | disclosed |
| EP-0113151-A2 | Printing medium and use thereof | International Business Machines Corporation (US) | 1984-07-11 | — | — | EP | disclosed |
| US-4297361-A | PREFERENTIAL ACTIVITY AGAINST BEETLES, MOTHS, AND FLIES | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-10-27 | — | — | US | disclosed |
| US-4277499-A | Combating insects with N-(substituted-phenyl)-N-(2-chloro-6-fluoro-benzoyl)-ureas | BAYER AKTIENGESELLSCHAFT (DE) | 1981-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410174-B1 | Small molecular inhibitors of sting signaling compositions and methods of use | STING1, IRF3, MAVS | ALDH1A1 4833/4885GAA 1184/4885CES2 4707/4885 |
| US-12545682-B2 | Heterocyclic derivatives as P2X7 receptor antagonists | P2RX7, P2RX3, P2RX1 | ALDH1A1 1416/4885GAA 4666/4885CES2 1858/4885 |
| US-12552804-B2 | Tricyclic heterocycles as FGFR inhibitors | FGFR3, FGFR1, FGFR2 | ALDH1A1 478/4885GAA 2760/4885CES2 1727/4885 |
| US-20250032473-A1 | QUINOLINE DERIVATIVES | CFTR, NQO1, IRF3 | ALDH1A1 476/4885GAA 252/4885CES2 1985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.